Clinical Trials Directory

Trials / Conditions / Advanced Malignant Tumor

Advanced Malignant Tumor

19 registered clinical trials studyying Advanced Malignant Tumor — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingPhase I Clinical Study of QLS-1304 in the Treatment of Patients With Advanced Malignant Tumors
NCT06823609
Qilu Pharmaceutical Co., Ltd.Phase 1
UnknownPhase I Clinical Study of SHR-5495 in the Treatment of Patients With Advanced Malignant Tumors
NCT06059508
Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1
Active Not RecruitingThe Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of JS207 in Patients With Advanced Malignant T
NCT06022250
Shanghai Junshi Bioscience Co., Ltd.Phase 1
UnknownPhase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors
NCT05851092
Shandong Suncadia Medicine Co., Ltd.Phase 1
UnknownPhase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors
NCT05416359
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1
CompletedA Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors
NCT05318833
Jiangsu HengRui Medicine Co., Ltd.Phase 1
UnknownClinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
NCT05198505
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Phase 1
SuspendedA Study to Evaluate the Cardiac Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Ad
NCT05089461
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Phase 2
UnknownA Clinical Trial of TQB3909 Tablets in Subjects With Advanced Malignant Tumors
NCT04975204
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1
CompletedBAT7104 Injection in Patients With Advanced Malignant Tumors.
NCT05767060
Bio-Thera SolutionsPhase 1
CompletedA First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
NCT05144061
Shanghai Hengrui Pharmaceutical Co., Ltd.Phase 1
CompletedEvaluation of LBL-003 Phase I Study in Patients With Advanced Malignancies
NCT05042908
Nanjing Leads Biolabs Co.,LtdPhase 1
CompletedPhase I/II Clinical Trial of LBL-015 for Injection
NCT05107011
Nanjing Leads Biolabs Co.,LtdPhase 1 / Phase 2
UnknownA Study to Investigate Safety and Tolerability of SH3765 Tablet in Patients With Advanced Malignant Tumor
NCT05015309
Nanjing Sanhome Pharmaceutical, Co., Ltd.Phase 1
UnknownA Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies
NCT04954456
Qilu Pharmaceutical Co., Ltd.Phase 1
UnknownAn Exploratory Clinical Study of LDP Combined With CDP1 in Patients With Advanced Malignant Tumor
NCT04739111
Dragonboat Biopharmaceutical Company LimitedPhase 1
UnknownA Study of TQ-B3101 Capsules in Subjects With Advanced Malignant Tumor
NCT04412564
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2
UnknownQL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors
NCT04326829
Qilu Pharmaceutical Co., Ltd.Phase 2
UnknownA Study of QL1706 in Subjects With Advanced Malignant Tumor
NCT04296994
Qilu Pharmaceutical Co., Ltd.Phase 1